Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds and methods for delivery of prostacyclin analogs

Compounds and methods for delivery of prostacyclin analogs

US Patent 9624156 · Granted Apr 18, 2017

Estimated economic value: $44,700,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of pulmonary arterial hypertension with prostacyclin-treated endotheli2025
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2025
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2023
Treatment of pulmonary arterial hypertension with prostacyclin-treated endotheli2023
Treprostinil prodrugs2023
Treatment of pulmonary arterial hypertension with mesenchymal stem cells2023
Compounds and methods for delivery of prostacyclin analogs2022
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2021
Compounds and methods for delivery of prostacyclin analogs2021
Treatment of pulmonary arterial hypertension with prostacyclin-treated endotheli2020
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2018
Treatment of pulmonary arterial hypertension with mesenchymal stem cells2018